These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21200020)

  • 41. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.
    Müller-Tidow C; Steffen B; Cauvet T; Tickenbrock L; Ji P; Diederichs S; Sargin B; Köhler G; Stelljes M; Puccetti E; Ruthardt M; deVos S; Hiebert SW; Koeffler HP; Berdel WE; Serve H
    Mol Cell Biol; 2004 Apr; 24(7):2890-904. PubMed ID: 15024077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AML-1-ETO-Mediated erythroid inhibition: new paradigms for differentiation blockade by a leukemic fusion protein.
    Choi Y; Elagib KE; Goldfarb AN
    Crit Rev Eukaryot Gene Expr; 2005; 15(3):207-16. PubMed ID: 16390317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrative genetic analysis of mouse and human AML identifies cooperating disease alleles.
    Hatlen MA; Arora K; Vacic V; Grabowska EA; Liao W; Riley-Gillis B; Oschwald DM; Wang L; Joergens JE; Shih AH; Rapaport F; Gu S; Voza F; Asai T; Neel BG; Kharas MG; Gonen M; Levine RL; Nimer SD
    J Exp Med; 2016 Jan; 213(1):25-34. PubMed ID: 26666262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure of the AML1-ETO NHR3-PKA(RIIα) complex and its contribution to AML1-ETO activity.
    Corpora T; Roudaia L; Oo ZM; Chen W; Manuylova E; Cai X; Chen MJ; Cierpicki T; Speck NA; Bushweller JH
    J Mol Biol; 2010 Sep; 402(3):560-77. PubMed ID: 20708017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiation.
    Bäsecke J; Schwieger M; Griesinger F; Schiedlmeier B; Wulf G; Trümper L; Stocking C
    Leuk Lymphoma; 2005 Feb; 46(2):265-72. PubMed ID: 15621811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death.
    Krejci O; Wunderlich M; Geiger H; Chou FS; Schleimer D; Jansen M; Andreassen PR; Mulloy JC
    Blood; 2008 Feb; 111(4):2190-9. PubMed ID: 17975013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.
    Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L
    Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Acute myeloid leukemia (aml) subtype M2 with variation of the t (8;21)translocation and AML1/ETO expression].
    Llimpe Y; Monteza R; Ticlahuanca J; Rubio P; Ortíz C; Arias A
    Rev Peru Med Exp Salud Publica; 2013 Mar; 30(1):145-6. PubMed ID: 23612831
    [No Abstract]   [Full Text] [Related]  

  • 50. Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia.
    Cho EK; Bang SM; Ahn JY; Yoo SM; Park PW; Seo YH; Shin DB; Lee JH
    Korean J Intern Med; 2003 Mar; 18(1):13-20. PubMed ID: 12760263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.
    Hong D; Gupta R; Ancliff P; Atzberger A; Brown J; Soneji S; Green J; Colman S; Piacibello W; Buckle V; Tsuzuki S; Greaves M; Enver T
    Science; 2008 Jan; 319(5861):336-9. PubMed ID: 18202291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of AML1-ETO fusion protein on the expression of BCL-2].
    Zhuang WY; Li ZY; Zhao Y; Cen JN; Zhuang WZ; Chen ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1394-8. PubMed ID: 24370018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Establishment of a pluripotent preleukaemic stem cell line by expression of the AML1-ETO fusion protein in Notch1-immortalized HSCN1cl10 cells.
    Delaney C; Bernstein ID
    Br J Haematol; 2004 May; 125(3):353-7. PubMed ID: 15086416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Establishment of leukemia cell model with inducible AML1-ETO expression and its effect on fatty acid metabolism in leukemia cells].
    Xie WQ; Yang X; Gu RX; Tian Z; Xing HY; Tang KJ; Rao Q; Qiu SW; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):366-372. PubMed ID: 37550185
    [No Abstract]   [Full Text] [Related]  

  • 55. The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell.
    Shima T; Miyamoto T; Kikushige Y; Yuda J; Tochigi T; Yoshimoto G; Kato K; Takenaka K; Iwasaki H; Mizuno S; Goto N; Akashi K
    Exp Hematol; 2014 Nov; 42(11):955-65.e1-5. PubMed ID: 25101977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.
    Higuchi M; O'Brien D; Kumaravelu P; Lenny N; Yeoh EJ; Downing JR
    Cancer Cell; 2002 Feb; 1(1):63-74. PubMed ID: 12086889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.
    Bakshi R; Zaidi SK; Pande S; Hassan MQ; Young DW; Montecino M; Lian JB; van Wijnen AJ; Stein JL; Stein GS
    J Cell Sci; 2008 Dec; 121(Pt 23):3981-90. PubMed ID: 19001502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single-cell RNA sequencing of a new transgenic t(8;21) preleukemia mouse model reveals regulatory networks promoting leukemic transformation.
    Yan M; Liu M; Davis AG; Stoner SA; Zhang DE
    Leukemia; 2024 Jan; 38(1):31-44. PubMed ID: 37838757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO.
    Da Silva N; Meyer-Monard S; Menot ML; Parrado A; Lebel A; Balitrand N; Fenaux P; Micléa JM; Rousselot P; Degos L; Dombret H; Chomienne C
    Hematol J; 2000; 1(5):316-28. PubMed ID: 11920209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.
    Dayyani F; Wang J; Yeh JR; Ahn EY; Tobey E; Zhang DE; Bernstein ID; Peterson RT; Sweetser DA
    Blood; 2008 Apr; 111(8):4338-47. PubMed ID: 18258796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.